The World Bank Working for a World Free of Poverty Microdata Library
  • Data Catalog
  • About
  • Collections
  • Citations
  • Terms of use
  • Login
    Login
    Home / Central Data Catalog / IMPACT_EVALUATION / BFA_2013_HRBFIE-FBL_V01_M / variable [F9]
impact_evaluation

Health Results-Based Financing Impact Evaluation 2013, Health Facility Baseline Survey

Burkina Faso, 2013 - 2014
Get Microdata
Reference ID
BFA_2013_HRBFIE-FBL_v01_M
DOI
https://doi.org/10.48529/sr1v-cr92
Producer(s)
Paul Jacob Robyn, Aurelia Souares, Herve Hien
Collection(s)
Impact Evaluation Surveys Fragility, Conflict and Violence
Metadata
Documentation in PDF DDI/XML JSON
Created on
Jan 13, 2017
Last modified
Jan 17, 2017
Page views
215922
Downloads
11029
  • Study Description
  • Data Description
  • Documentation
  • Get Microdata
  • Related datasets
  • Data files
  • f1_healthworkers_aug19
  • f1_main_aug19
  • f1_usehf_aug19
  • f2_aug19
  • f3_aug19
  • f4_aug19
  • f5_aug19
  • f6_aug19
  • f7_aug19
  • f8_aug19

F7_220_Médicament acheté 5 (f7_220_5)

Data file: f7_aug19

Overview

Valid: 231
Invalid: 0
Type: Discrete
Start: 994
End: 1019
Width: 26
Range: -
Format: character

Questions and instructions

Categories
Value Category Cases
ACT 1
0.4%
ACT 75MG COMPRIME 1
0.4%
ACT ADOLESCANT 1
0.4%
ACT ADULTE 2
0.9%
ACT COMP 1
0.4%
ACT COMP PARACETAMOL COMP 1
0.4%
ALBENDAZOLE 8
3.5%
ALBENDAZOLE CP 1
0.4%
ALBENDAZOLE CP 03 1
0.4%
ALCOOL 1
0.4%
AMOTI SIROP 1
0.4%
AMOTI SIROP 01 1
0.4%
AMOTI SIROP 02 1
0.4%
AMOXI 1
0.4%
AMOXICILLINE 1
0.4%
AMOXICILLINE 500MG GEL 1
0.4%
AMOXICILLINE CP 1
0.4%
AMOXICILLINE GEL 1
0.4%
AMOXICILLINE GL 1
0.4%
AMOXICILLINE SIROP 1
0.4%
AMP 1G INJECT 1
0.4%
AMPI 2
0.9%
AMPICILLINE 1G 1
0.4%
AMPICILLINE 1G INJ 1
0.4%
AMPICILLINE ASL 1
0.4%
AMPICILLINE INJ 1
0.4%
ARTESUNATE 1
0.4%
ASAQ 1
0.4%
ASL 12
5.2%
ASL + CARBOTOUX 1
0.4%
ASL + SERINGUE 1
0.4%
ASL 900INJ 1
0.4%
ASL 900MG 3
1.3%
ASL 900MG 1 1
0.4%
ASL INJ 1
0.4%
ASL INJ SERINGUE 1
0.4%
ASL INJECTABLE 1
0.4%
ASL;EPPI 1
0.4%
ASLYSINE 1
0.4%
ASPEGIC,VITAMINE C 1
0.4%
BANDE 5
2.2%
BANDE DE CREPE 1
0.4%
BANDE GANTS 1
0.4%
BANDES 1
0.4%
BBP 1
0.4%
BETADINE 3
1.3%
BETADINE JAUNE 1
0.4%
BUTY 1
0.4%
CARBOCISTEINE CHLOR 1
0.4%
CARBOCYSTEINE 1
0.4%
CARBOCYSTEINE 2% 1
0.4%
CARBOTOUX 2
0.9%
CARBOTOUX 5% SIROP 1
0.4%
CARBOTOUX SIROP 2
0.9%
CEFTRIAXONE 1G INJ 1
0.4%
CEPHASPIRE 1
0.4%
CHLOPHE 1
0.4%
CHLORPHENERAMINE CP 1
0.4%
CHLORPHENIRAMINE 5
2.2%
CHLORPHENIRAMINE CP 3
1.3%
CIPRO 1
0.4%
CLOXACILLINE 1
0.4%
CLOXACILLINE GELULE 1
0.4%
COMPLEXE 2
0.9%
COMPRESS XYLOCAINE 1
0.4%
COMPRESSE 2
0.9%
COMPRESSE 40X40 1
0.4%
COTRI 1
0.4%
COTRIMOXAZOLE 7
3%
COTRIMOXAZOLE 480MG 1
0.4%
COTRIMOXAZOLE COMPRIME 1
0.4%
COTRIMOXAZOLE CP 1
0.4%
COTRINIDAZOLE 480MG 1
0.4%
COTRINOXAZOLE 1
0.4%
DIAZEPAM INJ 1
0.4%
DICLO CP 1
0.4%
DICLOFENAC 1
0.4%
DICLOFENAC COMPRIME 1
0.4%
DICLOFENAC INJ 1
0.4%
EFFERALGAN CP 500 1
0.4%
EPPI 2
0.9%
EPPI SERINGUE 1
0.4%
ERYTHROMYCINE 2
0.9%
FER CP 1
0.4%
FUROSEMIDE 1
0.4%
FUROSEMIDE CP 1
0.4%
GAN 1
0.4%
GANT 3
1.3%
GANT SERINGUE 1
0.4%
GANT SERINGUE METOCLOPRAMI 1
0.4%
GANTS 1
0.4%
GANTS STERILE 1
0.4%
HPV 2
0.9%
HPV INJECTABLE 1
0.4%
HYDROCORTISONE 1
0.4%
HYDROCORTISONE 100MG 1
0.4%
IBUPROFEN 15
6.5%
IBUPROFEN 400MG 2PLAQETTES 1
0.4%
LAME 1
0.4%
LUMARTEM 1
0.4%
MEBENDAZOLE 1
0.4%
METOCLOPHAMIDE 1
0.4%
METRO 2
0.9%
METRONIDAZOLE 1
0.4%
METRONIDAZOLE 250MG 1
0.4%
METRONIDAZOLE CP 1
0.4%
METRONIDAZOLE INJ 1
0.4%
MULTI VITAMINE 1
0.4%
MULTIVITAMINE 2
0.9%
MULTIVITAMINE COMPRIME 1
0.4%
NOVALGIN CP 1
0.4%
NOVALGIN INJ 1
0.4%
OMEPRAZOLE CP 1
0.4%
OMEPRAZOLE GEL 1
0.4%
PARACETAMOL 4
1.7%
PARACETAMOL 500 1
0.4%
PARACETAMOL 500MG CHLORE 1
0.4%
PARACETAMOL 500MG COMP 1
0.4%
PARACETAMOL CP + BUTHYL 1
0.4%
PARACETAMOL+SGI 5% 500CC 1
0.4%
PARACETAMOL,QUININE 1
0.4%
PENI V 2
0.9%
PERFUSEUR + INTRANULE 1
0.4%
PHLOROGLUCINOL COMPRIME 1
0.4%
PHLOROGLUCINOL INJ 1
0.4%
PHONO;6 HYDRO, 7 CEPHI 500 1
0.4%
POLINDONE 1
0.4%
POLYVIDONE 1
0.4%
POTION KUNAN 1
0.4%
QUININE 0,40 1
0.4%
QUININE 400 MG 2
0.9%
QUININE 400MG INJ 1
0.4%
QUININE INJECTABLE 1
0.4%
QX3000 1
0.4%
SERINGUE 5
2.2%
SERINGUE 5CC 1
0.4%
SERINGUE GANTS D EX5PAIRES 1
0.4%
SERUM GLUCOSE ISOTONIQUE 1
0.4%
SGI 1
0.4%
SGI 280 ML 1
0.4%
SMECTA SACHET 1
0.4%
SOLUTION GLUCOSE HYDROCORT 1
0.4%
SPANADROP 1
0.4%
SPARADRAP GANT DIAZEPAM 1
0.4%
SRO 3
1.3%
SULFAMETHOXAZOLE 1
0.4%
TIG 1
0.4%
VAT 3
1.3%
VIT C 1
0.4%
VITAMINE C COMP 1
0.4%
VITAMINE K1 HYDROSOL POLYV 1
0.4%
XYLOCAINE 1
0.4%
ZINC CP 1
0.4%
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.
Back to Catalog
The World Bank Working for a World Free of Poverty
  • IBRD IDA IFC MIGA ICSID

© The World Bank Group, All Rights Reserved.

This site uses cookies to optimize functionality and give you the best possible experience. If you continue to navigate this website beyond this page, cookies will be placed on your browser. To learn more about cookies, click here.